Clinical trial
An Efficacy & Safety Study of BMS-512148 in Combination With Metformin Extended Release Tablets
NCT00643851
Study timeline
Study start (unknown)2008-06-01Date precision: month
Registry last updated2023-01-30
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Type 2 Diabetesunresolved
Interventions
DapagliflozinDRUG · verified · RxNorm: dapagliflozin
Metformin XRDRUG
Sponsors & collaborators
AstraZenecalead sponsor
Bristol-Myers Squibbcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00643851 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.